Displaying 401 - 410 of 756 results
Finding Novel Therapy Targets for Hemangiosarcoma to Advance Treatment
Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.
Developing A Test for Early Detection of Splenic Hemangiosarcoma
Researchers will study changes in microRNAs in the blood of dogs enrolled in the Golden Retriever Lifetime Study and diagnosed with hemangiosarcoma to identify early disease biomarkers.
Studying the Role of a Hormone in Pancreatic Tumors
Researchers will study how the hormone ghrelin influences the development of canine pancreatic cancer to identify early disease biomarkers.
Identifying Diagnostic and Therapeutic Targets for Splenic Hemangiosarcoma
Researchers will use a novel approach to differentiate between cancerous and normal cells surrounding splenic hemangiosarcoma tumors to improve successful tumor removal and drug delivery.
Categorizing Mammary Tumors to Provide Better Prognostic Assessment
This study investigates whether DNA-based markers can be used to improve methods for categorizing feline mammary cancers into subgroups based on probable outcome.
Developing Novel Chemotherapy Delivery System
Researchers will investigate a novel nanoparticle system to deliver chemotherapy drugs directly to osteosarcoma tumors, the most common bone cancer in dogs.
Maximizing the Scientific Use of Golden Retriever Lifetime Study Data
Researchers will standardize and improve organization of data collected from 3,000+ dogs enrolled in Morris Animal Foundation’s Golden Retriever Lifetime Study to expand access and research opportunities.
Evaluating a New Treatment for Canine Osteosarcoma
Researchers will evaluate the safety and efficacy of a novel combination of checkpoint inhibitor and adoptive T-cell therapy in giant-breed dogs diagnosed with appendicular osteosarcoma, a type of primary bone cancer of the limbs.